BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 7678345)

  • 1. The multidrug resistance (mdr1) gene product functions as an ATP channel.
    Abraham EH; Prat AG; Gerweck L; Seneveratne T; Arceci RJ; Kramer R; Guidotti G; Cantiello HF
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):312-6. PubMed ID: 7678345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies.
    Buschman E; Arceci RJ; Croop JM; Che M; Arias IM; Housman DE; Gros P
    J Biol Chem; 1992 Sep; 267(25):18093-9. PubMed ID: 1381362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the multidrug transporter.
    Germann UA
    Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
    Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
    J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability.
    Roman RM; Lomri N; Braunstein G; Feranchak AP; Simeoni LA; Davison AK; Mechetner E; Schwiebert EM; Fitz JG
    J Membr Biol; 2001 Oct; 183(3):165-73. PubMed ID: 11696858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the multidrug resistance an ATP channel?
    Arias IM
    Hepatology; 1993 Jul; 18(1):216-7. PubMed ID: 7686878
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1.
    Hoof T; Demmer A; Hadam MR; Riordan JR; Tümmler B
    J Biol Chem; 1994 Aug; 269(32):20575-83. PubMed ID: 7914197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
    Azzaria M; Schurr E; Gros P
    Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoproteins: mediators of multidrug resistance.
    Germann UA; Pastan I; Gottesman MM
    Semin Cell Biol; 1993 Feb; 4(1):63-76. PubMed ID: 8095827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein.
    Gill DR; Hyde SC; Higgins CF; Valverde MA; Mintenig GM; Sepúlveda FV
    Cell; 1992 Oct; 71(1):23-32. PubMed ID: 1382860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterization of the mouse multidrug resistance gene family.
    Dhir R; Buschman E; Gros P
    Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
    Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
    Choi KH; Chen CJ; Kriegler M; Roninson IB
    Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary studies of a monoclonal antibody raised to the over expressed plasma membrane associated glycoprotein of a multidrug resistant cell line.
    Moran E; Redmond A; Clynes M
    Biochem Soc Trans; 1992 Feb; 20(1):58S. PubMed ID: 1353037
    [No Abstract]   [Full Text] [Related]  

  • 15. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein.
    Valverde MA; Díaz M; Sepúlveda FV; Gill DR; Hyde SC; Higgins CF
    Nature; 1992 Feb; 355(6363):830-3. PubMed ID: 1371598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae.
    Kuchler K; Thorner J
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2302-6. PubMed ID: 1347948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein expression in classical multi-drug resistant leukaemia cells does not correlate with enhanced chloride channel activity.
    Wang X; Wall DM; Parkin JD; Zalcberg JR; Kemm RE
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):101-8. PubMed ID: 7913667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of human MDR1 mRNA by a hammerhead ribozyme.
    Kobayashi H; Dorai T; Holland JF; Ohnuma T
    FEBS Lett; 1993 Mar; 319(1-2):71-4. PubMed ID: 8095909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
    Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance: molecular biology and clinical relevance.
    Rothenberg M; Ling V
    J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.